pentobarbital will decrease the extent or impact of fosaprepitant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will lessen the level or effect of bazedoxifene/conjugated estrogens by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will lessen the level or result of glecaprevir/pibrentasvir by influencing hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will reduce the extent or influence of cortisone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

pentobarbital will minimize the extent or outcome of diltiazem by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

pentobarbital will lessen the extent or result of alfentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.

pentobarbital will reduce the extent or result of oliceridine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. If coadministration by using a CYP3A4 inducer is necessary, consider escalating oliceridine dose right until stable drug effects are reached; keep track of for signs of opioid withdrawal.

pentobarbital will decrease the level or outcome of nitrendipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Not known.

pentobarbital will reduce the extent or effect of stiripentol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. If unable to stay clear of coadministration of stiripentol with strong CYP3A4 inducers, enhance stiripentol dose.

pentobarbital will lower the level or effect of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is often a delicate CYP3A4 substrate. Coadministration with strong or moderate CYP3A4 inducers is contraindicated.

pentobarbital will lessen the extent or effect of fosamprenavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

buprenorphine transdermal and pentobarbital each maximize sedation. Steer clear of or Use Alternate Drug. Limit use to clients for whom option treatment method options are inadequate

pentobarbital will reduce the level or result of mifepristone by influencing hepatic/intestinal enzyme CYP3A4 click here metabolism. Use Warning/Keep track of. CYP3A4 inducers haven't been examined, coadministration not advisable by producer

pentobarbital will lessen the extent or outcome of iloperidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.